Electrodeionization Products help advance water purification.

Press Release Summary:




FEDI®-2Rx Fractional Electrodeionization products are designed for pharmaceutical, biomedical, and laboratory applications where installations require hot water sanitization to meet pharmacopoeia standards for Purified Water (PW) and Water For Injection (WFI). With dual voltage technology, FEDI represents next generation of electrodeionization (EDI) technology for production of high-purity water.



Original Press Release:



QUA® Introduces Next Generation of Advanced Water Purification with FEDI®-2Rx Pharma Line of Electrodeionization Products



CHARLEROI, PA, USA – QUA®, a leading-edge developer of advanced membrane products for water and wastewater treatment applications, has launched FEDI®-2Rx Fractional Electrodeionization product range specially designed for applications in pharmaceutical, biomedical and laboratory applications where installations require hot water sanitization to meet pharmacopoeia standards for Purified Water (PW) and Water For Injection (WFI).



“After successful acceptance of our industrial range of FEDI, we are now ready to service the pharma, medical, biomedical, cosmetics and laboratory arena with our innovative product range branded as FED-2 Rx. We are confident that our patented process of manufacturing ion exchange media will provide improved reliability of performance in these applications,” said V J Nathan, Technical Director, QUA Group.



In a short span of two years, the QUA Group’s FEDI has more than 25 global installations including various sites in USA, Europe and Asia. The company recently received the 2013 Frost & Sullivan New Product Innovation Award for Industrial Water & Wastewater Treatment Technology, North America, for FEDI Electrodeionization and its Q-SEP® Hollow Fiber Ultrafiltration Modules.



With patented dual voltage technology, QUA’s FEDI technology is the next generation of electrodeionization (EDI) technology for the production of high purity water. Developed taking into account the limitations of conventional EDI, the FEDI process improves the reliability of EDI for the production of high purity water.



About QUA

QUA (www.quagroup.com) develops, manufactures and markets advanced membrane products to treat challenging waters. Headquartered in the USA, the company also operates facilities in Europe and India. The company is committed to ongoing innovation, leveraging its deep roots in R&D and the expertise of staff that is highly experienced in water treatment technologies. QUA manages the entire lifecycle and manufacturing chain of its products from the initial concept to manufacturing according to the most rigorous quality standards. QUA products are sold and serviced through a global network of qualified equipment manufacturers.

More from Test & Measurement

All Topics

COVID-19 Response Suppliers COVID-19 Response:
Can Your Company Help Provide Critical Supplies?

We are using the power of our platform to aid in the mass shortage of critical supplies. If your company can help provide supplies, capabilities, or materials for products such as N-95 Masks and Tyvek SuitsPlease let us know.

COVID-19 Response Suppliers